Related Experiment Video
Updated: May 28, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Cardiac resynchronisation therapy response predicts occurrence of atrial fibrillation in non-ischaemic dilated
S L D'Ascia1, C D'Ascia, V Marino
1Division of Cardiology, Department of Clinical Medicine, Cardiovascular and Immunologic Sciences, Federico II University, Naples, Italy.
Insights
Cardiac resynchronization therapy (CRT) may prevent new-onset atrial fibrillation (AF) in patients with non-ischaemic dilated cardiomyopathy. Non-responders to CRT showed a significantly higher incidence of AF over three years.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Non-ischaemic idiopathic-dilated cardiomyopathy is a significant cause of severe heart failure.
- Atrial fibrillation (AF) is a common complication in heart failure patients.
- Cardiac resynchronization therapy (CRT) is a treatment option for selected heart failure patients.
Purpose of the Study:
- To evaluate the effect of CRT on the incidence of new-onset AF.
- To assess long-term AF development in responders versus non-responders to CRT.
- To investigate CRT's role in preventing AF in a specific heart failure population.
Main Methods:
- Prospective, single-centre study involving 58 AF-naïve patients receiving CRT.
- Patients were categorized as responders (72.4%) or non-responders (27.6%) after 1 year.
- AF incidence was compared between groups at 1, 2, and 3 years post-implantation.
Main Results:
- Non-responders had a significantly higher incidence of new-onset AF at 1 year (18.2% vs. 3.3%, p < 0.05).
- This difference persisted at 2 years (33.3% vs. 12.2%) and 3 years (50.0% vs. 15.0%).
- Three-year follow-up showed non-responders had a 5.67-fold increased risk of developing new-onset AF.
Conclusions:
- CRT may have a protective effect against new-onset AF in patients with non-ischaemic dilated cardiomyopathy.
- Patient response to CRT is a critical factor in AF prevention.
- This study highlights CRT's potential as a non-pharmacological strategy for AF prevention in this cohort.
Aim:
The aim of this study was to determine whether or not cardiac resynchronization therapy (CRT) has a favourable effect on the incidence of new-onset atrial fibrillation (AF) in a homogeneous population of patients with non-ischaemic idiopathic-dilated cardiomyopathy and severe heart failure.
Methods:
We designed a single-centre prospective study and enrolled 58 patients AF naïve when received CRT. After 1 year of follow-up our population was subdivided into responders (72.4%) and non-responders (27.6%), so as to compare the incidence of AF after 1, 2 and 3 years of follow-up in these two groups.
Results:
Already after 1 year, there was a significant (p < 0.05) difference in new-onset AF in non-responder patients with respect to responders (18.2% vs. 3.3%). These data were confirmed at 2 years (33.3% vs. 12.2%) and 3 years (50.0% vs. 15.0%) follow-up. In particular, 3 years after device implantation non-responders had an increased risk to develop new-onset AF (OR = 5.67).
Conclusions:
This is the first study analysing long-term effects of CRT in a homogeneous population of patients with non-ischaemic dilated cardiomyopathy, indicating the favourable role of this non-pharmacological therapy on the prevention of AF.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy V: Interprofessional Care
Cardiopulmonary Resuscitation III: AED Use
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

